Next Article in Journal
EGFR-Based Targeted Therapy for Colorectal Cancer—Promises and Challenges
Next Article in Special Issue
Detection of Anti-SARS-CoV-2-S1 RBD-Specific Antibodies Prior to and during the Pandemic in 2011–2021 and COVID-19 Observational Study in 2019–2021
Previous Article in Journal
Phase 3 Randomized, Multicenter, Placebo-Controlled Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of an Adjuvanted Cell Culture-Derived, H5N1 Subunit Influenza Virus Vaccine in Healthy Adult Subjects
Previous Article in Special Issue
COVID-19 in China and the US: Differences in Hospital Admission Co-Variates and Outcomes
 
 
Article

Article Versions Notes

Vaccines 2022, 10(4), 496; https://doi.org/10.3390/vaccines10040496
Action Date Notes Link
article xml file uploaded 24 March 2022 03:41 CET Original file -
article xml uploaded. 24 March 2022 03:41 CET Update -
article pdf uploaded. 24 March 2022 03:41 CET Version of Record https://www.mdpi.com/2076-393X/10/4/496/pdf-vor
article supplementary file uploaded. 24 March 2022 03:41 CET - https://www.mdpi.com/2076-393X/10/4/496#supplementary
article html file updated 24 March 2022 03:43 CET Original file -
article xml file uploaded 8 April 2022 03:40 CEST Update -
article xml uploaded. 8 April 2022 03:40 CEST Update https://www.mdpi.com/2076-393X/10/4/496/xml
article pdf uploaded. 8 April 2022 03:40 CEST Updated version of record https://www.mdpi.com/2076-393X/10/4/496/pdf
article html file updated 8 April 2022 03:41 CEST Update -
article html file updated 1 August 2022 07:16 CEST Update https://www.mdpi.com/2076-393X/10/4/496/html
Back to TopTop